FDA warns of severe joint pain risk with DPP-4 diabetes drugs 28.08.2015 23:44 Reuters (Reuters) - A class of diabetes drugs that include Merck & Co Inc's Januvia has been linked with severe joint pain, the U.S. Food and Drug Administration said on Friday.
